EPISODE · Apr 21, 2021 · 13 MIN
GRACEcast- ASCO LUNG 2020- The SINDAS Trial - The Addition of SBRT to a Systemic EGFR inhibitor TKI in EGFR positive NSCLC
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
Drs. H. Jack West, Helena Yu and David Spigel discuss The SINDAS Trial - The Addition of SBRT to a Systemic EGFR inhibitor TKI in EGFR positive NSCLC
Embed this episode
Ready to play
GRACEcast- ASCO LUNG 2020- The SINDAS Trial - The Addition of SBRT to a Systemic EGFR inhibitor TKI in EGFR positive NSCLC
0:00
13:31
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?
This episode is 13 minutes long.
When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?
This episode was published on April 21, 2021.
Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!